Helene Highbarger

机构：Frederick National Laboratory for Cancer Research, Science Applications International Corporation (United States)

发表论文 22 篇 · 总被引 496 次 · h-index 7

代表论文

• Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics (2013 · JAMA · 被引 290)
• The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 (2022 · Annals of Internal Medicine · 被引 63)
• Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial (2023 · The Lancet Respiratory Medicine · 被引 19)
• Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19 (2024 · Clinical Infectious Diseases · 被引 16)
• Natural Occurring Polymorphisms in HIV-1 Integrase and RNase H Regulate Viral Release and Autoprocessing (2021 · Journal of Virology · 被引 14)
• SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir (2024 · The Journal of Infectious Diseases · 被引 13)